Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans

Cited by (203)

Items 101–200 of 203

1. Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity
   Yao Xu, Yang Ze Xiao, Cheng Luo, Qingxia Liu, Aiqi Wei, Yang Yang, Liwen Zhao, Yong Wang · 2020 · International Immunopharmacology
2. Development and Qualification of a Scale-Down Mammalian Cell Culture Model and Application in Design Space Development by Definitive Screening Design
   Lei Nie, Dong Gao, Haiyan Jiang, Jin-Xia Gou, Lei Li, Feng Hu, Tingting Guo, Haibin Wang, Haibin Qu · 2019 · AAPS PharmSciTech
3. An FDA perspective on the assessment of proposed biosimilar therapeutic proteins in rheumatology
   Nikolay P. Nikolov, Marjorie A. Shapiro · 2017 · Nature Reviews Rheumatology
4. Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product
   Neung‐Seon Seo, Zhe Huang, Scott T. Kuhns, Heather Sweet, Shawn Cao, Mats Wikström, Jennifer Liu · 2020 · Biologicals
5. A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies
   Gargi Roy, Tom Martin, Arnita S. Barnes, Jihong Wang, Rod Brian Jimenez, Megan Rice, Lina Li, Hui Feng, Shu Jie Zhang, Raghothama Chaerkady et al. · 2018 · mAbs
6. High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
   Ximo Zhang, Corey E. Reed, Robert E. Birdsall, Ying Qing Yu, Weibin Chen · 2020 · SLAS TECHNOLOGY
7. DigiGlyc: A hybrid tool for reactive scheduling in cell culture systems
   Pavlos Kotidis, Iosif S. Pappas, Styliana Avraamidou, Efstratios N. Pistikopoulos, Cleo Kontoravdi, Maria M. Papathanasiou · 2021 · Computers & Chemical Engineering
8. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development
   Lowell J. Brady, Jyoti Velayudhan, Devi B Visone, Ken C Daugherty, Jeff L Bartron, Michael E. Coon, Cabot Cornwall, Peter Hinckley, Lisa Connell‐Crowley · 2015 · mAbs
9. N-glycomic profiling of capsid proteins from Adeno-Associated Virus serotypes
   Yongjing Xie, Michael Butler · 2023 · Glycobiology
10. The Mannose in the Mirror: A Reflection on the Pharmacokinetic Impact of High Mannose Glycans of Monoclonal Antibodies in Biosimilar Development
    Joel Welch, Cristina Ausín, Nina N. Brahme, Emanuela Lacaná, Stacey Ricci, Marlene Schultz‐DePalo · 2022 · Clinical Pharmacology & Therapeutics
11. Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective
    Yanli Zhuang, Di Chen, Amarnath Sharma, Zhenhua Xu · 2018 · The AAPS Journal
12. N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical
    Fabian Higel, Andreas Seidl, Uwe M. Demelbauer, Margot Viertlboeck-Schudy, Vera Koppenburg, Ulrich O. Kronthaler, F. Sörgel, Wolfgang Frieß · 2015 · Pharmaceutical Research
13. Decoding the mannose receptor-mAb interaction: the importance of high-mannose N-glycans and glycan-pairing
    Julia Baumeister, Maximilian Meudt, Sybille Ebert, F. Rosenau, B. Mizaikoff, Michaela Blech, K. M. Aertker, Fabian Higel · 2024 · mAbs
14. Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications
    Sen Yang, Ming Cui, Qiaofei Liu, Quan Liao · 2022 · Cancer Letters
15. Inhibition of glycosylation on a camelid antibody uniquely affects its FcγRI binding activity
    Natalie Krahn, Maureen A. Spearman, Markus Meier, July Dorion-Thibaudeau, Matthew McDougall, Trushar R. Patel, Grégory De Crescenzo, Yves Durocher, Jörg Stetefeld, Michael Butler · 2016 · European Journal of Pharmaceutical Sciences
16. The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans
    Dung Ngoc Pham Nguyen, Richard L. Redman, Satoru Horiya, Jennifer K. Bailey, Bokai Xu, Robyn L. Stanfield, J. Sebastian Temme, Celia C. LaBranche, Shiyu Wang, Avital Adah Rodal et al. · 2020 · ACS Chemical Biology
17. Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity
    Jenny Calow, Anna‐Janina Behrens, Sonja Mader, Ulrike Bockau, Weston B. Struwe, David John Harvey, Kai U. Cormann, Marc M. Nowaczyk, Karin Loser, Daniel Schinor et al. · 2016 · mAbs
18. Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies
    Jean-François Bruxelle, Tess Kirilenko, Quratulain Qureshi, Naiomi Lu, Nino Trattnig, Paul Kosma, Ralph A. Pantophlet · 2020 · Scientific Reports
19. Expression and Display of Glycoengineered Antibodies and Antibody Fragments with an Engineered Yeast Strain
    Anjali Shenoy, Srisaimaneesh Yalamanchili, Alexander R. Davis, Adam W. Barb · 2021 · Antibodies
20. An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin
    Sagit Shalel‐Levanon, Orit Aharonovitz, Ayelet Maor-Shoshani, Gita Abraham, Dan Kenett, Yehoshua Aloni · 2018 · Journal of Biotechnology
21. Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting
    Thomas Kissner, Guenter Blaich, Andreas Baumann, Sven Kronenberg, Adam Hey, Andrea Kießling, Petra M. Schmitt, Wouter H. P. Driessen, Chantal Carrez, Daniel Kramer et al. · 2021 · mAbs
22. Offsetting Low-Affinity Carbohydrate Binding with Covalency to Engage Sugar-Specific Proteins for Tumor-Immune Proximity Induction
    Benjamin P. M. Lake, Anthony F. Rullo · 2023 · ACS Central Science
23. Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC–MS/MS-Based Glycoproteomic Approach
    Jingfu Zhao, Wenjing Peng, Xue Dong, Yehia S. Mechref · 2020 · Journal of Proteome Research
24. Modulation of high mannose levels in N ‐linked glycosylation through cell culture process conditions to increase antibody‐dependent cell‐mediated cytotoxicity activity for an antibody biosimilar
    Shahid Rameez, Yogender Kumar Gowtham, Gautam Nayar, Sigma S. Mostafa · 2021 · Biotechnology Progress
25. Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics
    Shufang Liu, Dhaval K. Shah · 2022 · Drug Metabolism and Disposition
26. Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate.
    Zhen-Duo Shen, Yan-Hong Wang, Hua-Rong Xu, Qian Zhang, Chun-Jie Sha, Bai-Ping Sun, Qing Li · 2021 · International Journal of Biological Macromolecules
27. Key Physicochemical Characteristics Influencing ADME Properties of Therapeutic Proteins
    Xing Jing, Yan Hou, William H. D. Hallett, Chandrahas G. Sahajwalla, Ping Ji · 2019 · Advances in experimental medicine and biology
28. A Draft of Human N-Glycans of Glycorna
    Ming Bi, Zirui Zhang, Tao Wang, Hongwei Liang, Zhixin Tian · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
29. Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing
    Adam J. Rish, Khandaker Siddiquee, Zhuangrong Huang, Jianlin Xu, Carl A. Anderson, Michael Borys, Anurag Khetan · 2023 · Biotechnology Journal
30. Streamlining biosimilar development based on 20 years’ experience
    Cecil Nick · 2024 · Expert Opinion on Biological Therapy
31. Benchmarking glycoform-resolved affinity separation – mass spectrometry assays for studying FcγRIIIa binding
    Christoph Gstöttner, Steffen Lippold, Michaela Hook, Feng Yang, Markus Haberger, Manfred Wuhrer, David Falck, Tilman Schlothauer, Elena Domínguez‐Vega · 2024 · Frontiers in Immunology
32. Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira)
    Dong Gao, Lei Nie, Junjie Yuan, Feng Hu, Zhenhua Wu, Qunhai Lin, Haibin Wang · 2021 · Journal of Pharmaceutical Sciences
33. Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs
    Gauri Pradhan, J.M. Sneha, Babasaheb P. Sonwane, B. Santhakumari, Alka Rao, Mahesh J. Kulkarni · 2020 · Journal of Proteomics
34. Glycosylation Profiling as a Biomarker of Suboptimal Health Status for Chronic Disease Stratification
    Xueqing Wang, Zhaohua Zhong, Lois A. Balmer, Wei Wang · 2021 · Advances in experimental medicine and biology
35. Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation
    Hannah Bauer-Smith, Abigail S. L. Sudol, Stephen A. Beers, Max Crispin · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
36. Optimization of the Process of Chinese Hamster Ovary (CHO) Cell Fed-Batch Culture to Stabilize Monoclonal Antibody Production and Overall Quality: Effect of pH Control Strategies
    Kexue Liang, Hongzhen Luo, Qi Li · 2024 · Fermentation
37. Multivariate quantitative analysis of glycan impact on IgG1 effector functions
    Tamara Cvijić, Matej Horvat, Jakob Plahutnik, Ana Golob, Jaka Marušič · 2024 · mAbs
38. Therapeutic proteins: facing the challenges of glycobiology
    Simone Albrecht, Mark Hilliard, Pauline Mary Rudd · 2014 · Journal of Health Policy & Outcomes Research
39. Highly variable aggregation and glycosylation profiles and their roles in immunogenicity to protein-based therapeutics
    Sina Sarsarshahi, Sanghati Bhattacharya, Zeb Ralph Zacharias, Eman S. Kamel, Jon C. D. Houtman, M. Reza Nejadnik · 2025 · Journal of Pharmaceutical Sciences
40. Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregates
    Allyson Kwiatkowski, Carl Co, Sei Kameoka, An Zhang, John E. Coughlin, Thomas O. Cameron, Eric T. Chiao, Svetlana Bergelson, Cullen L. Schmid · 2020 · mAbs
41. Fast and Ultrasensitive Glycoform Analysis by Supercritical Fluid Chromatography–Tandem Mass Spectrometry
    Yoshimi Haga, Masaki Yamada, Risa Fujii, Naomi Saichi, Takashi Yokokawa, Toshihiro Hama, Yoshihiro Hayakawa, Koji Ueda · 2022 · Analytical Chemistry
42. Generation of site‐distinct N‐glycan variants for in vitro bioactivity testing
    David Brühlmann, T. Vuillemin, Abhijeet Satwekar, E. Galano, A. Palmese, A. D’Angelo, Zeynep Manco, J. Souquet, H. Broly, M. Sauer et al. · 2019 · Biotechnology and Bioengineering
43. Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria®(golimumab)
    Jill L. Kinzer, Troy A. Halseth, Jukyung Kang, Sang Yeop Kim, Preethi Kumaran, Michael Ford, Sergei V. Saveliev, St John Skilton, Anna A. Schwendeman · 2023 · International Journal of Pharmaceutics
44. Biolayer Interferometry-based FcγRIIa binding assay for a therapeutic antibody with strong effector function
    Adriana Bajardi-Taccioli, Carl Co, Christine M Bond, Allyson Masci, Tim Brantley, Chong‐Feng Xu, Svetlana Bergelson, Marina S. Feschenko · 2020 · Analytical Biochemistry
45. Detection and Quantitation of Low Abundance Oligosaccharides in Recombinant Monoclonal Antibodies
    Gomathinayagam Ponniah, Christine Nowak, Nidia Gonzalez, Dino Miano, Hongcheng Liu · 2015 · Analytical Chemistry
46. Heterogeneity of IgGs: Role of Production, Processing, and Storage on Structure and Function
    Chris Barton, David Spencer, Sophia V. Levitskaya, Jinhua Feng, Reed J. Harris, Mark A. Schenerman · 2014 · ACS symposium series
47. Antigen-presenting cell internalization is key for understanding and evaluating therapeutic antibodies’ immunogenicity
    Maria Lteif, Marc J. Pallardy, Isabelle Turbica · 2025 · Frontiers in Immunology
48. Tractable Method for Rapid Quality Assessment of Therapeutic Antibodies in Harvested Cell Culture Fluid based on FcγRIIIa-Immobilized Magnetic Microspheres
    Jianan Feng, Linlin Jiang, Yiqing Cao, Chunhui Deng, Yan Li · 2022 · Analytical Chemistry
49. Combinatory glycoengineering of monoclonal antibodies and its application in cancer therapy: a narrative review
    Siyuan Wang, Huairu Tian, Peilin Tian, Yiwen Xing, Yuan Zeng · 2024 · Translational Cancer Research
50. “Small is beautiful” – Examining reliable determination of low-abundant therapeutic antibody glycovariants
    Katharina Böttinger, Christof Regl, Veronika Schäpertöns, Erdmann Rapp, Therese Wohlschlager, Christian G. Huber · 2024 · Journal of Pharmaceutical Analysis
51. Comparison of glycoprofiles of rituximab versions licensed for sale in India and an analytical approach for quality assessment.
    T. Kaur, Bhupendra Nath Shukla, V. Yadav, M. Kulkarni, A. Rao · 2021 · Journal of Proteomics
52. Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus
    Cho Eun Kang, Seungeun Lee, Dong Hye Seo, Woon Heo, Sun Hyung Kwon, JeongRyeol Kim, Jinu Lee, Hisashi Koiwa, Hisashi Koiwa, Joo Young Kim et al. · 2021 · Molecular Biotechnology
53. Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes
    Steffen Lippold, Karishma Mistry, Sunidhi Lenka, Kevin Whang, Peilu Liu, Sebastian Pitschi, Felix Kuhne, Dietmar Reusch, Lance Cadang, Alexander Knaupp et al. · 2023 · Frontiers in Immunology
54. Predicting pharmacokinetic profile of therapeutic antibodies after iv injection from only the data after sc injection in cynomolgus monkey
    Kenta Haraya, Tatsuhiko Tachibana, Jun‐ichi Nezu · 2016 · Xenobiotica
55. Spotlight on Glycan Pairing: The Generation and Impact of Monoclonal Antibody Asymmetrical Fc N-Glycan Pairs on Fc Receptor Interaction
    Maximilian Meudt, Julia Baumeister, Erik M.F. Machal, Matthias J. Knape, Boris Mizaikoff, Sybille Ebert, Frank Rosenau, Michaela Blech, Fabian Higel · 2025 · ACS Pharmacology & Translational Science
56. Survey on the Role of Comparative Efficacy Studies Required for Biosimilar Monoclonal Antibody Approval in Japan to Justify the Quality Attribute Differences Between Biosimilars and Their Reference Products Based on the Pharmaceuticals and Medical Devices Agency (PMDA) Assessments
    Kanoko Goto, Aya Hariu, Ryosuke Kuribayashi · 2025 · Pharmaceutical Medicine
57. Selective clearance of monoclonal antibodies via the mannose receptor is dependent on glycan pairing
    Julia Baumeister, Maximilian Meudt, Wei Wei, Sybille Ebert, F. Rosenau, B. Mizaikoff, Michaela Blech, Lin-Zhi Chen, Fabian Higel · 2026 · Scientific Reports
58. MS‐Based Glycome Characterization of Biotherapeutics With N‐ and O‐Glycosylation
    Myung Jin Oh, Youngsuk Seo, Nari Seo, Hyun Joo An · 2025 · Mass Spectrometry Reviews
59. In silico mediated workflow for rapid development of downstream processing: Orthogonal product-related impurity removal for a Fc-containing therapeutic
    Dongyoun Jang, Scott Howard Altern, Steven M. Cramer · 2024 · Journal of Chromatography A
60. A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology.
    Sudhakar Voruganti, Jiahui Xu, Xia Li, G. Balakrishnan, Surinder M. Singh, Sambit R. Kar, Tapan K. Das · 2020 · Journal of Pharmacy and Science
61. Rapid Antibody Glycoengineering in CHO Cells Via RNA Interference and CGE-LIF N-Glycomics
    Pavlos Kotidis, Masue M. Marbiah, Roberto Donini, Itzcóatl A. Gómez, Ioscani Jiménez del Val, Stuart M. Haslam, Karen Marie Polizzi, Cleo Kontoravdi · 2021 · Methods in molecular biology
62. A simple enzyme–substrate localized conjugation method to generate immobilized, functional glutathione S-transferase fusion protein columns for affinity enrichment
    John E. Coughlin, Allyson Masci, Robert S. Gronke, Svetlana Bergelson, Carl Co · 2016 · Analytical Biochemistry
63. Plant-related quality attributes affecting FcγRIIIa binding: affinity chromatography analysis of rituximab glycovariants from Nicotiana benthamiana
    Sara Tengattini, Aurora Tini, Carla Marusic, Francesca Rinaldi, Isabella Senini, Enrica Calleri, Virginia Perez, Claudio Pisano, Marcello Donini, Caterina Temporini · 2025 · Frontiers in Plant Science
64. Strategies to evaluate potential effector function of glycan variants: A case study of ordesekimab (AMG 714 or PRV-015)
    Yu-Ling Wei, Teresa C. Wegesser, Scott T. Kuhns, Jonathan A. Werner, Herve N. Lebrec, Xiaoting Wang · 2022 · Journal of Immunotoxicology
65. Maduramycin, a novel glycosylation modulator for mammalian fed-batch and steady-state perfusion processes
    Patrick Romann, Thomas Vuillemin, Silvia Pavone, M. Jordan, Arnaud Périlleux, Jonathan Souquet, Jean‐Marc Bielser, Christoph Herwig, Thomas K. Villiger · 2024 · Journal of Biotechnology
66. An Automated Tool for Glycosimilarity Assessment of mAb Therapeutic Biosimilars: Trastuzumab and Bevacizumab as Case Studies
    Anuj Shrivastava, Sanjeet S. Patil, Rohan Shah, Anurag Singh Rathore · 2025 · BioDrugs
67. Development of a kinetic antibody-dependent cellular cytotoxicity assay
    Lynn A. Kamen, Tara G. Thakurta, Srividya Myneni, Kai Zheng, Shan Chung · 2019 · Journal of Immunological Methods
68. The origins of nonideality exhibited by monoclonal antibodies and Fab fragments in human serum
    Hayli A. Larsen, William M. Atkins, Abhinav Nath · 2023 · Protein Science
69. Metabolic and Process Engineering to Control Glycan Structures for Biopharmaceuticals Produced in Cultured Mammalian Cells
    Ranya Pranomphon, Vijay Tejwani, Hussain Dahodwala, Montarop Yamabhai, Susan T. Sharfstein · 2024 · Springer eBooks
70. Early De-risking Strategy for Novel Biotherapeutics
    Padma Kumar Narayanan, Rafael A. Ponce, Beth Hinkle · 2013 · Elsevier eBooks
71. Sequence Variant and Posttranslational Modification Analysis During Cell Line Selection via High-Throughput Peptide Mapping
    Chong‐Feng Xu, Yan Wang, P. A. Bryngelson, Zoran Sosic, Li Zang · 2019 · Advances in experimental medicine and biology
72. Developing a medium combination to attain similar glycosylation profile to originator by DoE and cluster analysis method
    Jian Jun Xu, Zhihui Shao, Zhanqing Wang, Yingfeng Huang, Xun Zou, Yaling Shen · 2021 · Scientific Reports
73. The Development of Methods to Account for Physiologic Dynamic Changes and Their Effects on the Pharmacokinetics of Therapeutic Monoclonal Antibodies and other Therapeutics
    Josiah T. Ryman · 2017
74. Process intensification for CHO cell biomanufacturing
    Markus Schulze · 2023
75. Advances in Techniques for the Structure and Functional Optimization of Therapeutic Monoclonal Antibodies
    Changxiang He, Weijin Huang, Xi Wu, Huanzhang Xia · 2025 · Biomedicines
76. Enhanced ADCC Activity of a C-Terminal Lysine Variant of an IgG1 Antibody Driven by N-Linked MAN5 Glycan Using a Reporter Gene Assay
    Ming-Ching Hsieh, Kristiina Dorofejeva, Jingming Zhang, Diane Vy, Jun Qian, Alice M. Matathia, Timothy Blanc, Chao Richard Li, Babita Saxena Parekh · 2025 · Antibodies
77. Bispecific single-domain antibody (VHH) fused with human IgG1 Fc with dual specificity effectively neutralize Naja Kaouthia venom
    Kanokporn Pothisamutyothin, Sirisak Sathorn, Ratchana Boonmee, Wichit Thaveekarn, Wanatchaporn Arunmanee · 2026 · PLoS neglected tropical diseases
78. Native Top-Down Mass Spectrometry Combined with High-Resolution Charge Variant Analysis of Trastuzumab Originator and Biosimilars
    Corentin Beaumal, Kristina Srzentić, Sara Carillo, Jonathan Bones · 2026 · Journal of the American Society for Mass Spectrometry
79. High-Throughput Quantification and Glycosylation Analysis of Antibodies Using Bead-Based Assays
    Sebastian Giehring · 2019 · Methods in molecular biology
80. Released N-Glycan Analysis for Biotherapeutic Development Using Liquid Chromatography and Mass Spectrometry
    Ximo Zhang · 2021 · Methods in molecular biology
81. Glycosylation analysis
    Christoph Gstöttner, Harleen Kaur, Manfred Wuhrer · 2021 · Elsevier eBooks
82. Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment
    Mar Castellanos, Dolores Fernández-Couto, Andrés da Silva‐Candal, María José Feal Painceiras, Manuel Rodríguez‐Yáñez, Carme Gubern, Juan Manuel Sánchez · 2023 · Separations
83. Simultaneous monitoring of monoclonal antibody variants by strong cation-exchange chromatography hyphenated to mass spectrometry to assess biosimilar-ity of rituximab-based biotherapeutics
    C. Huber, Fiammetta Di Marco, Thomas Berger, Wolfgang Esser-Skala, E. Rapp, Christof Regl · 2021
84. Mass spectrometric analysis of therapeutic proteins and complex biological samples
    Suli Liu · 2013
85. Discussion on Characterization and Quality Control Strategies of Antibody N-Glycosylation
    雪玲 居 · 2021 · Pharmacy Information
86. The study of culture redox potential’s effect on glycosylation and production of monoclonal antibodies in mammalian cell cultures
    Ben Dionne · 2015 · Mspace (University of Manitoba)
87. Glycosylation
    Maureen A. Spearman, Erika Lattová, Hélène Perreault, Michael Butler · 2018 · Wiley eBooks
88. Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality Assurance
    Itzcóatl A. Gómez, Ioscani Jiménez del Val · 2021 · Cell engineering
89. Drug Safety
    2013 · Drug Safety
90. Novel method to specifically determine the structures of non-N297 glycans in IgGs
    Gaurang P. Bhide, Natalie E Bohrer, Danying Song, Jeanne Cabel, Marc R. Lake, John E. Harlan, Laura J. Miesbauer · 2023 · Glycobiology
91. Physicochemical and functional characterization of monoclonal antibodies for lot release (part 2)
    Harleen Kaur · 2024 · Elsevier eBooks
92. Early de-risking strategy for biotherapeutics
    Padma Kumar Narayanan, Anna Dahlman, Ping Peng · 2024 · Elsevier eBooks
93. Modulation of N-glycosylation in bispecific antibody biosimilars through combined modulators
    Shengnan Xu, Pan Wang, Liu Xiaojing, Wang Xiaofei, Jiaqi Mao, Lin Yunfei, Li Guozhu, Qin Guohong, Dan Xu · 2025 · Protein Expression and Purification
94. IgE based therapeutics are an emerging modality in cancer treatment
    Kumari Shikha, Sanjay Ghosh, Achim Doerner · 2025 · Discover Oncology
95. Anti-CD38 VLRB-Fc antibodies from transgenic tobacco exhibit potent anti-myeloma activity in vitro and in vivo
    Caiquan Jin, Jun Li, Yerin Kim, Kibum Kim, Peter Hinterdorfer, Sang-Gu Kang, Jae‐Min Lim, Chang‐Ki Min, Min Eui Hong, Kisung Ko · 2025 · International Journal of Biological Macromolecules
96. Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody
    Mónica A. Farías, Catalina A. Andrade, Ricardo A. Loaiza, Linmar Rodríguez‐Guilarte, José T. Muñóz, Patricia Pereira-Sánchez, Natalia Muñoz‐Durango, Magdalena S. Pizarro-Ortega, Benjamín Diethelm‐Varela, Alejandra Pereira-Serrano et al. · 2026 · EBioMedicine
97. Engineered OAA lectins as selective and sensitive high mannose glycan targeting tools
    Bryce E. Ackermann, Emerson L. Hall, Vanessa T. Mariscal, Alex E. Clark, Kevin D. Corbett, Aaron F. Carlin, Alex J. Guseman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
98. On the use of glycoengineering methods for the generation of antibodies with enhanced effector functions
    Benjamin Serafin, Olivier Henry, Grégory De Crescenzo · 2026 · Glycobiology
99. Ingénierie métabolique de la voie de N-Glycosylation chez la diatomée Phaeodactylum tricornutum
    Rodolphe Dumontier · 2020
100. Computationally inspired glycoengineering to maximise mAb β4-galactosylation
     Itzcóatl A. Gómez, Mina Ghahremanzamaneh, Apostolos Tsopanoglou, Alfonso Blanco, Sara Carillo, Jonathan Bones, Ioscani Jiménez del Val · 2026 · Metabolic Engineering